SaulE.RivkinMD

Hematology • Seattle, WA

Founder and Chairman - Rivkin Center for Ovarian Cancer

Join to view full profile

Are you Dr. Rivkin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 57 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1221 Madison St
Seattle, WA 98104
Phone+1 206-386-2323

Fax+1 206-386-2729
Is this information wrong?

Summary

Dr. Saul Rivkin, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with Swedish Cherry Hill Campus, St. Anne Hospital, and Providence Swedish Edmonds.

Education & Training

University of New Mexico School of MedicineResidency, Internal Medicine, 1970 - 1971
University of New Mexico School of MedicineResidency, Internal Medicine, 1965 - 1968
University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1964 - 1965
University of Washington School of MedicineClass of 1964

Certifications & Licensure

WA State Medical License 1965 - 2022

Clinical Trials

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
Completed
Phase 3
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 May 01
Completed
Phase 3
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone Start of enrollment: 2006 May 01
Withdrawn
Phase 3
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients Start of enrollment: 2005 Aug 01
Completed
Phase 1, Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Start of enrollment: 2006 Oct 01
Completed
Phase 3
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
Completed
Phase 2
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Start of enrollment: 2007 Oct 12
Active, not recruiting
Phase 3
S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia Start of enrollment: 2007 Nov 15
Completed
Phase 2
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Mar 12
Active, not recruiting
Phase 2
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
Active, not recruiting
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery Start of enrollment: 2008 Oct 01
Completed
Phase 1
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2008 Dec 01
Active, not recruiting
Phase 2
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2008 Dec 01
Completed
Phase 2
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
Completed
Phase 2
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer Start of enrollment: 2009 Feb 01
Completed
Phase 2
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery Start of enrollment: 2008 Dec 01
Completed
Phase 2
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
Completed
Phase 2
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 2
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity Start of enrollment: 2009 Jan 01
Completed
Phase 1
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia Start of enrollment: 2009 Dec 10
Completed
Phase 2
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer Start of enrollment: 2010 Apr 01
Completed
Phase 2
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Start of enrollment: 2010 Nov 15
Active, not recruiting
Phase 1, Phase 2
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2011 Jul 01
Withdrawn
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Start of enrollment: 2010 Dec 01
Completed
Phase 2
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 2011 Jan 07
Completed
Phase 2
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Start of enrollment: 2010 May 01
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer Start of enrollment: 2011 Jan 01
Completed
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy Start of enrollment: 2011 Aug 09
Active, not recruiting
Phase 2
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy Start of enrollment: 2012 Feb 01
Completed
Phase 3
S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma Start of enrollment: 2011 Nov 01
Completed
Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Start of enrollment: 2012 Aug 01
Unknown status
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

11 citations
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
Saul E. Rivkin, James Moon, Desiree Iriarte, Erik Bailey, Heather L. Sloan, Gary E. Goodman, Amy E. Bondurant, Dan Velijovich, Tanya A. Wahl, Peter Jiang, Chirag A. Sh...> ;International Journal of Gynecological Cancer. 2019 Jan 29
15 citations
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
Mihaela C. Cristea, Paul Frankel, Timothy W. Synold, Saul E. Rivkin, Dean Lim, Vincent Chung, Joseph Chao, Mark T. Wakabayashi, Benjamin Paz, Ernest S. Han, Paul Lin, ...> ;Cancer Chemotherapy and Pharmacology. 2019 Jan 8
17 citations
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.
David Chu, Michael A. Hussey, Frank L. Meyskens, Cecilia M. Fenoglio-Preiser, Saul E. Rivkin, Glenn Mills, Jeffrey K. Giguere, Charles D. Blanke, Gary E. Goodman, Davi...> ;Clinical Colorectal Cancer. 2011 Dec 1
478 citations
Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergro...
Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O'Reilly, Patrick J. Flynn, Kendrith M. Rowland, James N. Atkins, B. Mirtsching, ...> ;Journal of Clinical Oncology. 2010 Aug 1
9 citations
Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy ...
Harriet O. Smith, James Moon, Sharon P. Wilczynski, Amy Tiersten, Edward V. Hannigan, William R. Robinson, Saul E. Rivkin, Garnet L. Anderson, Poching Liu, Maurie Markman> ;Gynecologic Oncology. 2009 Aug 1
46 citations
Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group–directed intergroup trial S9003
Antje Hoering, Morie A. Gertz, Saul E. Rivkin, Jackie Szymonifka, John Crowley, Bart Barlogie> ;Blood. 2009 Jan 22
3 citations
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Onco...
Deborah T. Blumenthal, Cathryn Rankin, Harmon J. Eyre, Robert B. Livingston, Alexander M. Spence, Keith J. Stelzer, Elisabeth J. Rushing, Mitchel S. Berger, Saul E. Ri...> ;Cancer. 2008 Aug 1
Phase I/II lapatinib plus carboplatin and paclitaxel in stage III or IV relapsed ovarian cancer patients.
Rivkin SE, Muller C, Iriarte D, Arthur J, Canoy A, Reid H> ;J. Clin. Oncol.. 2008-05-20
9 citations
Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, d...
Celestia S. Higano, Catherine M. Tangen, Wael Sakr, James R. Faulkner, Saul E. Rivkin, Frederick J. Meyers, Maha Hussain, Laurence H. Baker, Kenneth J. Russell, E. Dav...> ;Cancer. 2008 May 15
68 citations
Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial
Karen L. Syrjala, Janet R. Abrams, Nayak L. Polissar, Jennifer Hansberry, Jeanne Robison, Stuart DuPen, Mark J. Stillman, Marvin Fredrickson, Saul Rivkin, Eric M. Feld...> ;Pain. 2008 Mar 1
11 citations
A Phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliom...
Lode J. Swinnen, Cathryn Rankin, Hetty Carraway, Kathy S. Albain, Jeannette J. Townsend, George Thomas Budd, Julie A. Kish, Saul E. Rivkin, Deborah T. Blumenthal> ;Journal of Neuro-Oncology. 2008 Feb 1
168 citations
Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study
Linda L. Garland, Cathryn Rankin, David R. Gandara, Saul E. Rivkin, Katherine Scott, Raymond B. Nagle, Andres J. P. Klein-Szanto, Joseph R. Testa, Deborah A. Altomare,...> ;Journal of Clinical Oncology. 2007 Jun 10
SWOG S0202: A phase II trial of gemcitabine and capecitabine in patients (pts) with unresectable or metastatic gallbladder cancer or cholangiocarcinoma.
Iqbal S, McCoy S, Lenz HJ, Rivkin SE, Atkins JN, Blanke CD> ;J. Clin. Oncol.. 2006-06-20
Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials.
Rivkin SE, Markman M, Petersen J, Montgomery R> ;J. Clin. Oncol.. 2006-06-20
57 citations
A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: A Southwest Oncology Group study
Robert P. Whitehead, Sheryl McCoy, Saul E. Rivkin, Howard M. Gross, Marcel E. Conrad, Gary C. Doolittle, Robert A. Wolff, J. Wendall Goodwin, Shaker R. Dakhil, James L...> ;Investigational New Drugs. 2006 May 11
2 citations
Progress in ovarian cancer research: proceedings of the 5th Biennial Ovarian Cancer Research Symposium.
Mary L. Disis, Saul E. Rivkin, Andre T. Baron, Maurie Markman, D. Connolly, Frederick R. Ueland, Elise C. Kohn, Edward L. Trimble, Jonathan S. Berek> ;International Journal of Gynecological Cancer. 2006 Mar 1
10 citations
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study
Robert P. Whitehead, Sheryl McCoy, Saul E. Rivkin, Marcus A. Neubauer, Shaker R. Dakhil, Heinz-Josef Lenz, Michael Tanaka, James L. Abbruzzese> ;Investigational New Drugs. 2006 Jan 28
90 citations
Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for ...
Laura F. Hutchins, Stephanie Green, Peter M. Ravdin, Danika Lew, Silvana Martino, Martin D. Abeloff, Alan P. Lyss, Craig Allred, Saul E. Rivkin, C. Kent Osborne> ;Journal of Clinical Oncology. 2005 Nov 20
50 citations
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study
Howard West, John Crowley, R. B. Vance, Wilbur A. Franklin, Robert B. Livingston, Shaker R. Dakhil, Jeffrey K. Giguere, Saul E. Rivkin, Michael J. Kraut, Kari Chansky,...> ;Annals of Oncology. 2005 Jul 1
Profile of ovarian cancer patients seeking information from a proprietary web-based decision support program.
Rivkin SE, Markman M, Markman MR, Belland A, Petersen J> ;J. Clin. Oncol.. 2005-06-01
SWOG S0102: A phase II study of docetaxel (DOC) and vinorelbine (VNR) + filgrastim for HER-2 negative, stage IV breast cancer.
Gralow J, Green S, Lew D, Barlow W, Dammann K, Somlo G, Rivkin S, Taylor S, Wong L, Livingston R> ;J. Clin. Oncol.. 2005-06-01
82 citations
Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Continuous Infusion and Levami...
Elizabeth Poplin, Jacqueline Benedetti, Norman C. Estes, Daniel G. Haller, Robert J. Mayer, R. M. Goldberg, Geoffrey R. Weiss, Saul E. Rivkin> ;Journal of Clinical Oncology. 2005 Mar 20
77 citations
Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.
Paul Sabbatini, Carol Aghajanian, Don S. Dizon, S. Anderson, Jakob Dupont, John V. Brown, William A. Peters, Andrew D. Jacobs, Aminder Mehdi, Saul E. Rivkin, Amy J. Ei...> ;Journal of Clinical Oncology. 2004 Nov 15
122 citations
Randomized, Placebo-Controlled Study of Oregovomab for Consolidation of Clinical Remission in Patients With Advanced Ovarian Cancer
Jonathan S. Berek, Peyton T. Taylor, Alan N. Gordon, Mary J. Cunningham, Neil J. Finkler, James W. Orr, Saul E. Rivkin, Birgit Schultes, Theresa L. Whiteside, Christop...> ;Journal of Clinical Oncology. 2004 Sep 1
Vascular endothelial growth factor expression and survival in node positive breast cancer patients treated with adjuvant therapy.
Rivkin SE, Gown AM, Malmgren JA, Tickman RJ, Atwood M, Iriarte D> ;J. Clin. Oncol.. 2004-07-15
Join now to see all

Press Mentions

Olaparib Tablet Safe in Pretreated Ovarian Cancer PatientsSeptember 10th, 2014

Grant Support

Southwest Oncology GroupNational Cancer Institute1985–2012
Small Instrumentation GrantNational Cancer Institute1993

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Swedish Cherry Hill CampusSeattle, Washington
St. Anne HospitalSeattle, Washington
Providence Swedish EdmondsEdmonds, Washington